Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis

A Jimenez-Pacheco, JM Franco, S Lopez… - … in Aging and Disease, 2017 - Springer
Despite being clinically described 150 years ago, the mechanisms underlying amyotrophic
lateral sclerosis (ALS) pathogenesis have not yet been fully understood. Studies in both …

[HTML][HTML] The cellular and molecular signature of ALS in muscle

E Anakor, WJ Duddy, S Duguez - Journal of Personalized Medicine, 2022 - mdpi.com
Amyotrophic lateral sclerosis is a disease affecting upper and lower motor neurons.
Although motor neuron death is the core event of ALS pathology, it is increasingly …

Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment

EF Goodall, KE Morrison - Expert reviews in molecular medicine, 2006 - cambridge.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterised by
loss of motor neurons. The cause of disease is unknown other than in the rare cases of …

Opinion: more mouse models and more translation needed for ALS

EMC Fisher, L Greensmith, A Malaspina… - Molecular …, 2023 - Springer
Amyotrophic lateral sclerosis is a complex disorder most of which is 'sporadic'of unknown
origin but approximately 10% is familial, arising from single mutations in any of more than 30 …

Current view and perspectives in amyotrophic lateral sclerosis

S Mathis, P Couratier, A Julian, P Corcia… - Neural Regeneration …, 2017 - journals.lww.com
Amyotrophic lateral sclerosis (ALS), identified as a distinct clinical entity by Charcot since the
end of the nineteenth century, is a devastating and fatal neurodegenerative disorder that …

Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities

A Joardar, E Manzo, DC Zarnescu - Current genetic medicine reports, 2017 - Springer
Abstract Purpose of Review Amyotrophic lateral sclerosis (ALS) is a progressive
neurodegenerative disease for which there is no cure and treatments are at best palliative …

Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities

P Soares, C Silva, D Chavarria, FSG Silva… - Ageing Research …, 2023 - Elsevier
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of upper and lower
motor neurons (MNs) leading to paralysis and, ultimately, death by respiratory failure 3–5 …

Therapeutic approaches targeting protein aggregation in amyotrophic lateral sclerosis

R Malik, M Wiedau - Frontiers in Molecular Neuroscience, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease that targets
motor neurons (MNs) in the brain and spinal cord. It leads to gradual loss of motor signals to …

The glutamate hypothesis in ALS: pathophysiology and drug development

H Blasco, S Mavel, P Corcia… - Current medicinal …, 2014 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …

[HTML][HTML] Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials

PH Gordon - Aging and disease, 2013 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS), first described by Jean-Martin Charcot in the 1870s, is
an age-related disorder that leads to degeneration of motor neurons. The disease begins …